₹949.05
−0.17%NSE close, 16 Nov 2026
−42.42%
Epigral is a small cap company, listed on NSE under the symbol EPIGRAL. At ₹949.05 a share, the market values the whole company at ₹4,094 crore.
In FY26, it reported sales of ₹2,527 crore and a net profit of ₹332 crore, an operating margin of 22.4%. Over the last three years, sales grew 17.7% a year and net profit grew 9.5% a year.
The market values the company at 14.4 times its profit over the last twelve months and 1.73 times its book value; its return on equity is 12.0% and its borrowings are 0.24 times its equity.
Promoters hold 68.83% of the shares. Foreign institutions hold 0.99%, and domestic institutions, mutual funds among them, 4.90%.
Over the past year the share price has fallen 43.2%, and it is 43.2% below its 52-week high.
₹ crore. Consolidated figures.
Transcript
Link of Recording
UNAUDITED FINANCIAL RESULTS - Q2 FY27
The financial results for the period ended September 30, 2026.
| Mar 2026 |
|---|
| Jun 2026 |
|---|
| Sep 2026 |
|---|
| Sales | 472 | 525 | 651 | 626 | 645 | 628 | 607 | 587 | 597 | 736 | 705 | 746 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Expenses | 349 | 369 | 475 | 448 | 463 | 454 | 443 | 455 | 494 | 568 | 526 | 610 |
| Operating profit | 123 | 155 | 176 | 178 | 183 | 173 | 163 | 132 | 103 | 169 | 179 | 136 |
| Operating margin | 26.0% | 29.6% | 27.1% | 28.5% | 28.3% | 27.6% | 26.9% | 22.5% | 17.2% | 22.9% | 25.4% | 18.2% |
| Other income | 2.5 | 1.5 | 2.4 | 5.6 | 3.9 | 3.4 | 8.3 | 1.7 | 5.6 | −0.6 | 4.1 | 5.8 |
| Interest | 20.2 | 13.7 | 14.3 | 27.3 | −0.1 | 11.8 | 23.4 | 21.8 | 11.0 | 15.8 | 7.2 | 10.8 |
| Depreciation | 30.9 | 30.4 | 33.5 | 32.3 | 32.9 | 34.0 | 41.5 | 42.3 | 42.8 | 41.7 | 42.9 | 44.2 |
| Profit before tax | 74.2 | 113 | 131 | 124 | 154 | 131 | 107 | 70.0 | 54.6 | 111 | 133 | 86.9 |
| Tax | 24.9 | 36.2 | 45.1 | 43.9 | 50.0 | 44.4 | −53.7 | 18.4 | 15.5 | 28.6 | 34.0 | 22.5 |
| Net profit | 49.1 | 77.3 | 85.9 | 81.3 | 104 | 86.9 | 161 | 51.2 | 39.1 | 81.0 | 99.7 | 65.1 |
| EPS (₹) | 11.81 | 18.60 | 20.67 | 19.57 | 24.25 | 20.14 | 37.25 | 11.87 | 9.07 | 18.76 | 23.12 | 15.09 |
₹ crore, financial years to March.
| Line | FY22 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| Sales | 1,551 | 1,929 | 2,550 | 2,527 |
| Expenses | 1,041 | 1,448 | 1,839 | 1,960 |
| Operating profit | 509 | 481 | 711 | 567 |
| Operating margin | 32.9% | 24.9% | 27.9% | 22.4% |
| Other income | 4.1 | 6.5 | 15.2 | 15.0 |
| Interest | 44.3 | 73.5 | 53.3 | 72.0 |
| Depreciation | 85.9 | 124 | 133 | 168 |
| Profit before tax | 383 | 291 | 540 | 342 |
| Tax | 131 | 94.9 | 183 | 8.8 |
| Net profit | 253 | 196 | 358 | 332 |
| EPS (₹) | 60.84 | 47.13 | 84.68 | 76.95 |
₹ crore, at each year's end and the latest half year.
₹ crore, by financial year, and the latest half year.
| Line | FY22 | FY25 | FY26 | 6M to Sep 2026 |
|---|---|---|---|---|
| From operations | 284 | 441 | 436 | 141 |
| From investing | −455 | −262 | −355 | −97.2 |
| From financing | 195 | −164 | −94.5 | −47.8 |
| Spent on fixed assets | −456 | −195 | −394 | −88.0 |
| Free cash flow | −172 | 246 | 41.4 | 52.9 |
Margins, returns, debt, tax and cash.
| Line | FY22 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| Net margin | 16.3% | 10.2% | 14.0% | 13.1% |
| Operating margin | 32.9% | 24.9% | 27.9% | 22.4% |
| Return on equity | – | 15.6% | 18.8% | 14.9% |
| Return on capital employed | – | 16.4% | 23.8% | 14.9% |
| Return on assets | – | 7.0% | 11.4% | 9.5% |
| Debt to equity | – | 0.77 | 0.31 | 0.25 |
| Interest coverage | 9.70 | 5.00 | 11.10 | 5.70 |
| Debt to assets | – | 0.34 | 0.19 | 0.16 |
| Current ratio | – | 0.64 | 1.57 | 1.16 |
| Quick ratio | – | 0.31 | 0.79 | 0.67 |
| Cash ratio | – | 0.00 | 0.04 | 0.01 |
| Asset turnover | – | 0.69 | 0.81 | 0.72 |
| Fixed asset turnover | – | 1.11 | 1.15 | 1.20 |
| Inventory turnover | – | 4.00 | 3.50 | 4.10 |
| Receivables turnover | – | 10.80 | 11.00 | 6.10 |
| Gross margin | – | 45.0% | 46.9% | 43.4% |
| Cash from operations to profit | 112.0% | – | 123.0% | 131.0% |
| Effective tax rate | 34.1% | 32.6% | 34.0% | 2.6% |
Conference Call on Monday, 2nd November, 2026 to discuss Q2 FY27 Results.
Investor / Analyst Plant Visit on Thursday, 22.10.2026
Press Release on Un-Audited Financial Results Q1 FY27
The financial results for the period ended Jun 30, 2026.
Significant increase in volume has been observed in Epigral Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the…
Significant increase in volume has been observed in Epigral Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the…